Date published:
Audience:
General public
Six companies will each receive a share of $3.75 million in funding and expert, hands-on support through the ANDHealth+ program to develop their commercial potential.
This investment will help turn their promising digital technologies into real treatments such as:
- a brain imaging analysis platform that uses artificial intelligence (AI) to better monitor and manage neurological diseases like dementia
- AI-driven medical imaging software to unlock personalised treatment options for people with cardiovascular disease
- digital scanning technology and software to create personalised, medical-grade compression garments for therapeutic uses.
ANDHealth received $19.75 million to support small to medium companies to develop technologies with commercial potential through the MRFF’s Medical Research Commercialisation initiative.
Read the media release for more information.
Learn about the MRFF.